Improved Protection of Rhesus Macaques against Intrarectal Simian Immunodeficiency Virus SIVmac251Challenge by a Replication-Competent Ad5hr-SIVenv/revand Ad5hr-SIVgagRecombinant Priming/gp120 Boosting Regimen
Open Access
- 1 August 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (15), 8354-8365
- https://doi.org/10.1128/jvi.77.15.8354-8365.2003
Abstract
In this study we investigated the ability of a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen to induce protective immunity in rhesus macaques against pathogenic simian immunodeficiency virusmac251. Immunization of macaques by two sequential administrations of the same recombinants by the same route resulted in boosting and persistence of SIV-specific cellular immune responses for 42 weeks past the initial immunization. Anti-SIV gp120 immunoglobulin G (IgG) and IgA antibodies were induced in secretory fluids, and all macaques exhibited serum neutralizing antibody activity. After intrarectal SIVmac251 challenge, all of the macaques became infected. However, relative protection, as assessed by statistically significant lower SIV viral loads in plasma at both acute infection and set point, was observed in 8 out of 12 immunized non-Mamu-A∗01 animals. Elevated mean cellular immune responses to Gag and Env, neutralizing antibody activity, and IgG and IgA binding antibody levels were observed in the eight protected macaques. Statistically significant correlations with protective outcome were observed for cellular immune responses to SIV Env and Gag and for SIV gp120-specific IgG antibodies in nasal and vaginal fluids. Two macaques that exhibited the greatest and most persistent viremia control also exhibited strong CD8+ T-cell antiviral activity. The results suggest that a spectrum of immune responses may be necessary for adequate control of viral replication and disease progression and highlight a potential role for nonneutralizing antibodies at mucosal sites.Keywords
This publication has 78 references indexed in Scilit:
- Potent, Persistent Cellular Immune Responses Elicited by Sequential Immunization of Rhesus Macaques with Ad5 Host Range Mutant Recombinants Encoding SIV Rev and SIV NefDNA and Cell Biology, 2002
- Prospects for Vaccine Protection Against HIV-1 Infection and AIDSAnnual Review of Immunology, 2002
- A Conformational C4 Peptide Polymer Vaccine Coupled with Live Recombinant Vector Priming Is Immunogenic But Does Not Protect against Rectal SIV ChallengeAIDS Research and Human Retroviruses, 2001
- Polyvalent Envelope Glycoprotein Vaccine Elicits a Broader Neutralizing Antibody Response but Is Unable To Provide Sterilizing Protection against Heterologous Simian/Human Immunodeficiency Virus Infection in Pigtailed MacaquesJournal of Virology, 2001
- Cross-protection in NYVAC–HIV-1-immunized/HIV-2-challenged but not in NYVAC–HIV-2-immunized/SHIV-challenged rhesus macaquesAIDS, 2000
- Retrospective Analysis of Viral Load and SIV Antibody Responses in Rhesus Macaques Infected with Pathogenic SIV: Predictive Value for Disease ProgressionAIDS Research and Human Retroviruses, 1999
- CD8+ Lymphocyte Antiviral Activity in Monkeys Immunized with SIV Recombinant Poxvirus Vaccines: Potential Role in Vaccine EfficacyAIDS Research and Human Retroviruses, 1999
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Immunogenicity of Recombinant Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees Following Intranasal AdministrationAIDS Research and Human Retroviruses, 1994
- Characterization of the Secreted, Native gp120 and gp160 of the Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 1990